Menstrual Cycle Clinical Trial
Official title:
(TRIBE) Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users
This study aims to use validated tools as well as new technology to examine changes in bleeding patterns among women who are initiating the copper T380A IUD.
New users of the intrauterine device (IUD) are most likely to discontinue use within the first six months after insertion. The most common reason for discontinuation of the copper IUD is symptoms related to bleeding. Research looking at disturbances in bleeding patterns among new IUD users is sparse and dated. Perceived changes in vaginal bleeding may impact method satisfaction, acceptability, and continuation. There is a need for updated research evaluating changes in bleeding patterns in order for providers to better counsel patients on what to expect during the months after initiation of an IUD. A variety of methods to evaluate bleeding profiles are available. The World Health Organization (WHO) published recommendations for methods of collection and analysis of bleeding patterns. The WHO method includes data collection on bleeding days (days when blood loss requires the use of a menstrual pad or tampon) and spotting days (when no protection was needed) using 90-day referent periods. A second tool, the pictorial blood loss assessment chart (PBAC) has been shown to be an inexpensive and objective method of assessing blood loss. The PBAC takes into consideration how heavy blood flow is as well as the number of sanitary napkins and tampons used. Additionally, new technologies (including mobile period tracking applications) have made retrospective collection of bleeding data more feasible and prospective data collection more accurate. This study aims to incorporate these validated tools as well as new technology to examine changes in bleeding patterns among women who are initiating the copper T380A IUD. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03708692 -
Menstrual Cycle Phases on Recovery and Cognitive Function
|
||
Recruiting |
NCT05683119 -
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
|
N/A | |
Completed |
NCT03708679 -
Effects of Menstrual Cycle on Preoperative Anxiety
|
||
Recruiting |
NCT05936424 -
Menstrual Cycle Phase Based Training
|
N/A | |
Recruiting |
NCT05802277 -
Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.
|
N/A | |
Recruiting |
NCT03299179 -
The Effects of the Female Hormones on Cerebral Perfusion
|
||
Not yet recruiting |
NCT05088122 -
Hormonal Effect of Different Menstrual Phases on Dynamic Balance in Postpubertal Females
|
||
Recruiting |
NCT06377306 -
Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes
|
||
Recruiting |
NCT06072391 -
Investigating the Endocrine-metabolic-immunological Axis During the Female Menstrual Cycle by Functional Genomics
|
||
Completed |
NCT06086262 -
Hand Grip Strength in Athletic and Non-Athletic Girls at Different Phases of Menstrual Cycle
|
||
Recruiting |
NCT04196595 -
Apple Women's Health Study
|
||
Recruiting |
NCT06214442 -
Effects of the Menstrual Cycle on Triceps Surae Properties in Women
|
||
Not yet recruiting |
NCT06426459 -
Social Media Usage in Adolescent Girls
|
||
Recruiting |
NCT06365515 -
Dopamine, Reward Learning and Sex Hormones
|
N/A | |
Active, not recruiting |
NCT05347667 -
Menstrual Cycle Phase Muscle Protein Synthesis
|
N/A | |
Completed |
NCT04286828 -
Position Sense, Balance, and Dual Task Performance at the Menstrual Cycle in Females With Multiple Sclerosis
|
||
Completed |
NCT05576740 -
Influence of Menstrual Cycle Stages on Female Athletes
|
||
Completed |
NCT00456222 -
Impact of Sleep Disruption on the Menstrual Cycle
|
N/A | |
Completed |
NCT00128726 -
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
|
Phase 1 | |
Not yet recruiting |
NCT06060574 -
Menstrual Cycle and Platelet-rich Fibrin
|